FDA Issues Guidance Documents On Exploratory INDs

Drug GMP Report
KEYWORDS control / FDA

The FDA has released a series of guidances and a final rule aimed at speeding products to market by streamlining the investigational new drug (IND) application process.

To View This Article:


Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $10.00